Sales & Marketing News | pharmaphorum

News

House Oversight Committee chair James Comer (r)

PBMs will face House committee grilling next week

The House Committee on Oversight and Accountability will quiz leaders of pharmacy benefit managers (PBMs) at a hearing next week, amid scrutiny of the sector's role in rising healthcare cos

News

GLP-1 bonanza spurs big investment at CDMO CordenPharma

CordenPharma has launched a €900 million ($981 million) investment programme to prepare for an expected surge in demand for peptide production capacity – driven by GLP-1 receptor agonists.

News

Investors take issue with Taisho Pharma’s buyout price

Two investment funds have decided to contest Taisho Pharma’s recently announced management buyout plan in court, after failing to reach an agreement on the price.

News

Bill that would cut down ‘patent thickets’ clears Senate

The US Senate has come together to pass a bill that aims to prevent pharma companies from filing multiple patents around biologic drugs as a way to delay biosimilar competitors.

News

FDA rejects Novo Nordisk’s weekly basal insulin

Novo Nordisk’s bid to provide a once-weekly basal insulin product for people with diabetes, reducing the number of injections needed, has hit a major hurdle in the US.

News

FTC said to be planning legal action against PBMs

The Federal Trade Commission in the US is planning to sue the owners of the three largest pharmacy benefits managers (PBMs) for anti-competitive behaviour, on the heels of its damning repor

PBMs will face House committee grilling next week

GLP-1 bonanza spurs big investment at CDMO CordenPharma

Investors take issue with Taisho Pharma’s buyout price

Bill that would cut down ‘patent thickets’ clears Senate

FDA rejects Novo Nordisk’s weekly basal insulin

FTC said to be planning legal action against PBMs

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks